Trial of Indication-Based Transfusion of Red Blood Cells in ECMO

Running, not enrolling · Not applicable

Conditions studied: Extracorporeal Membrane Oxygenation, Red Blood Cell Transfusion, Organ Failure, Multiple

In brief

TITRE - Trial of Indication-based Transfusion of Red Blood Cells in ECMO, is a multicenter, prospective, randomized clinical trial. The overarching goal of TITRE is to determine whether restricting red blood cell (RBC) transfusion according to an indication-based strategy for those with bleeding and/or deficit of tissue oxygen delivery, compared with transfusion based on center-specific hemoglobin or hematocrit thresholds, can reduce organ dysfunction and improve later neurodevelopment in critically ill children receiving Extracorporeal Membrane Oxygenation (ECMO) support.

Key facts

Study ID
NCT05405426
Run by
Boston Children's Hospital
People needed
228
Starts
2023-04-14
Expected to finish
2026-12-01
Last updated by the study team
2026-07-02

Who can join

Age: any, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.